ArticleBlood advances2019

Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitor.

Margaret Nieborowska-Skorska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.